395 MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor, in combination with erlotinib: clinical and preclinical experience

✍ Scribed by A. Patnaik; J. Besterman; A.W. Tolcher; M. Mehran; M. Drouin; C. Maroun; C. Bonfils; M. Beeram; R. Martell; K. Papadopoulos

• Book ID: 119603078
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 62 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)72102-9